Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1 pseudogene 13 (UBE2V1P13) is a non-functional genomic DNA sequence in humans related to the functional UBE2V1 gene, which encodes a member of the ubiquitin-conjugating enzyme E2 family. Pseudogenes like UBE2V1P13 arise by duplication or retrotransposition but typically do not encode functional proteins due to disruptive mutations, deletions, or absence of necessary regulatory elements. UBE2V1P13 is not expressed as a protein and does not play an active role in biological pathways or disease, nor is it a target for therapeutics. It is distinct from the protein-coding UBE2V1 gene, which has been studied for its role in differentiation, cell cycle, and interaction with UBE2N, but pseudogenes like UBE2V1P13 do not inherit those functions[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBE2V1 pseudogene 13 (UBE2V1P13).